Very early researchStudy completedNCT00486421
What this trial is testing
Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura
Who this might be right for
Nonneoplastic Condition
Mayo Clinic 22
Showing 20 of 21 results